Related Experiment Video
Updated: May 14, 2026

08:32
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Improving safety in autologous HSCT for systemic sclerosis
John A Snowden1, Mohammed Akil, David G Kiely
1Department of Haematology, Sheffield Teaching Hospitals National Health Service Foundation Trust and University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF, UK. john.snowden@sth.nhs.uk
Lancet (London, England)
|February 1, 2013
Summary
No abstract available in PubMed .
